Attorney Referrals Blog En EspaƱol
Buffalo Personal Injury Lawyers Attorney Profiles Results Practice Areas Info Center Contact a New York Injury Attorney
Personal Injury Practice Areas
Dangerous Drugs
Acetaminophen
Accutane
Actos
Alli
Avandia
Baycol
Bextra
Cardura
Celexa
Celebrex
Chantix
Darvon - Darvocet
Digitek
Enbrel
Ephedra
Fen-Phen
Fentanyl (Duragesic)
Fosamax
Gadolinium (MRI Injection)
Glyburide
Hydroxycut
Ketek
Lamisil
Levaquin
Lexapro
Lipitor
Lotronex
Lymerix
Meridia
Methadone
Morphine Sulfate
Neurontin
OrthoEvra
Oxycontin
Quinine
Pain Pumps
Paxil
Phenylpropanolamine
Prempro
Propulsid
ReNu Recall
Rezulin
Rituxan
Stadol
Serevent and Advair
Synthroid
Tequin
Terbutaline
Topamax
Topical Anesthetic
Trasylol (Aprotinin)
Vaccination Litigation (VICP)
Viagra
Vioxx
Vytorin
Yaz
Zicam
Zithromax (Azithromycin)
Zyban
Zyban
Zyban
Zyban
 

   

   
Dangerous Drugs
 

Phenylpropanolamine

New York (NY) - Phenylpropanolamine Lawyer Helping Dangerous Drug Victims

The Food and Drug Administration (FDA) issued a public health advisory concerning phenylpropanolamine hydrochloride. This drug is widely used as a nasal decongestant (in over-the-counter and prescription drug products) and for weight control (in over-the-counter drug products). The FDA is taking steps to remove phenylpropanolamine from all drug products and has requested that all drug companies discontinue marketing products containing phenylpropanolamine.

Phenylpropanolamine has been marketed for many years. A recent study reported that taking phenylpropanolamine increases the risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is very low, FDA recommends that consumers not use any products that contain phenylpropanolamine.

FDA's Nonprescription Drugs Advisory Committee (NDAC) recently discussed this study and other information on phenylpropanolamine. NDAC determined that there is an association between phenylpropanolamine and hemorrhagic stroke and recommended that phenylpropanolamine not be considered safe for over-the-counter use.

Although this risk of hemorrhagic stroke is very low, FDA has significant concerns because of the seriousness of a stroke and the inability to predict who is at risk. FDA does not consider the conditions for which phenylpropanolamine is used (over-the-counter or by prescription) as justifying the risk of this serious event. Other products are available for use.

In the meantime, consumers can identify over-the-counter cough-cold, nasal decongestant, and weight control products containing this ingredient by looking for "phenylpropanolamine" in the list of active ingredients on the label. Consumers can check with their health care provider or pharmacist to see whether their prescription cough-cold or nasal decongestant product contains phenylpropanolamine. We advise consumers to discuss alternative over-the-counter and prescription products with their health care providers or pharmacists.

If you or loved one have been injured as a result of taking the above drug, you may have a valid claim. Call us now at 1-800-621-2020 or contact us.

Back To Dangerous Drugs

 
 
 
Manhattan Office
420 Lexington Avenue
17th Floor
New York, NY  10170
(800) 621-2020
Maps & Directions
Garden City Office
600 Old Country Road
Suite 500
Garden City, NY 11530
(800) 621-2020
Map & Directions

Melville Office
68 South Service Road
Suite 100
Melville, NY  11747
(800) 621-2020
Map & Directions
Buffalo Office:
350 Main Street
2500 Main Place Tower
Buffalo, NY 14202
(716) 854-2020
(800) 621-2020
Map & Directions
Rochester Office:
16 W. Main Street
Powers Building, Suite 600
Rochester, NY 14614
(585) 454-2020
(800) 621-2020
Map & Directions
Grider Street Office:
451 Grider Street
Buffalo, NY 14215
(716) 854-2020
(800) 621-2020
Map & Directions
361761:Phenylpropanolamine,361647:Dangerous Drugs,361647:Dangerous Drugs,361385:Personal Injury Practice Areas